Outset Medical, Inc. - Common Stock (OM)
Healthcare › Electromedical & Electrotherapeutic Apparatus
Price History
Feb 9, 2026 — Apr 1, 2026Investment Snapshot
- P/B of 0.55 — trading below book value
- Piotroski F-Score 7/9 — financially strong with improving fundamentals
- Loss-making — negative ROE of -71.0%
- Revenue growing at 5% annually
Outset Medical, Inc. - Common Stock (OM) is a Healthcare company operating in Electromedical & Electrotherapeutic Apparatus, listed on the NASDAQ , with a market capitalisation of $70 million . Key value metrics: P/B ratio 0.55, Piotroski F-Score 7 out of 9 (strong financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Outset Medical, Inc. - Common Stock — Fundamental Analysis Summary
On financial health, OM shows a strong Piotroski F-Score of 7/9, indicating improving fundamentals across profitability, leverage, and efficiency, and negative return on equity of -71.0% (sector average: -19.8%), and manageable leverage with a debt-to-equity ratio of 0.76.
StockPik's composite Value Score for OM is 77/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
OM reports a moderate gross margin of 37.2% (sector average: 33.5%) and a negative operating margin of -61.1%.
OM shows revenue growing at 5% year-over-year, with earnings growing at 36%.